Citation

Douglas D. Richman, M.D. Susceptibility to nucleoside analogues of zidovudine-resistant isolates of human immunodeficiency virus. American Journal of Medicine. 1990 May 21; 88(Suppl 5B):8S-10S.

Citation

Fred Richard Sattler, M.D., Carmen Joseph Allegra, M.D., Thomas D. Verdegem, Bisher Akil, M.D., Carmelita U. Tuazon, M.D., Claire Hughlett, Debra M. Ogata-Arakaki, R.N., Judith Feinberg, M.D., James Shelhamer, M.D., H. Clifford Lane, M.D., Roger Davis, C. Thomas Boylen, John M. Leedom, M.D., Henry Masur, M.D. Trimetrexate-leucovorin dosage evaluation study for treatment of pneumocystis carinii pneumonia. Journal of Infectious Diseases. 1990 Jan 01; 161(1):91-6.

Citation

Greg Spear, Ph.D., Alan Landay, Ph.D., Brenda L. Sullivan, B. Dittel, T. F. Lint. Activation of complement on the surface of cells infected by human immunodeficiency virus. Journal of Immunology. 1990 Feb 15; 144(4):1490-6.

Citation

Jashvant D. Unadkat, Ph.D., Ann C. Collier, M.D., Dana Cummings, A.R.N.P., Kent Opheim, Lawrence Corey, M.D. Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat meal. AIDS. 1990 Mar 01; 4(3):229-32.

Citation

Paul Volberding, M.D., Stephen W. Lagakos, Ph.D., Matthew A. Koch, M.D., Carla Pettinelli, M.D., Ph.D., Maureen Myers, Ph.D., David K. Booth, P.A., Henry H. Balfour, Jr., M.D., Richard C. Reichman, M.D., John Alexander Bartlett, M.D., Martin S. Hirsch, M.D., Robert L. Murphy, M.D., W. David Hardy, M.D., Ruy Soeiro, M.D., Margaret A. Fischl, M.D., John G. Bartlett, M.D., Thomas C. Merigan, Jr., M.D., Newton E. Hyslop, Jr., M.D., Douglas D. Richman, M.D., Fred T. Valentine, M.D., Lawrence Corey, M.D. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. New England Journal of Medicine. 1990 Apr 05; 322(14):941-9.

Citation

Henry H. Balfour, Jr., M.D. Management of cytomegalovirus disease with antiviral drugs. Reviews of Infectious Diseases. 1990 Sep 01; 12(Suppl 7):S849-60.

Citation

David H. Schwartz, M.D., Ph.D., Thomas C. Merigan, Jr., M.D. Interleukin-2 in the treatment of HIV disease. Biotherapy. 1990 Jan 01; 2(2):119-36.

Citation

Stephen W. Lagakos, Ph.D., Lony C.L. Lim, J. Robins. Adjusting for early treatment termination in comparative clinical trials. Statistics In Medicine. 1990 Dec 01; 9(12):1417-24.

Citation

Greg Spear, Ph.D., Brenda L. Sullivan, Alan Landay, Ph.D., T. F. Lint. Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis. Journal of Virology. 1990 Dec 01; 64(12):5869-73.

Citation

Gildon Beall, M.D., Sally Kruger, M.S., F. Morales, D. Imagawa, J. A. Goldsmith, D. Fisher, James Paul Steinberg, M.D., John P. Phair, M.D., S. Whaling, J. Bitran. A double-blind, placebo-controlled trial of thymostimulin in symptomatic HIV-infected patients. AIDS. 1990 Jul 01; 4(7):679-81.